56 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LLY

Eli Lilly
US$750.00-2.0%52.4%US$823.9bUS$810.17PE113xE28.5%0.6%

NOVOB

Novo Nordisk
DKK 86.710%45.7%DKK 3.1tDKK 86.54PE40.7xE15.2%1.0%

943981

Johnson & Johnson
US$140.050.4%-4.3%US$396.8bUS$146.16PE24.1xE7.2%3.0%

10683053

Merck
US$100.472.1%n/aUS$297.2bUS$119.21PE21.6xE14.4%2.6%

ROG

Roche Holding
CHF 269.201.4%7.9%CHF 216.6bCHF 301.11PE20.2xE10.8%3.6%

RO

Roche Holding
CHF 288.601.2%7.5%CHF 216.6bCHF 322.80PE20.2xE10.8%3.6%

982352

AstraZeneca
UK£132.50-9.9%11.4%UK£182.6bUK£155.24PE37.8xE16.4%1.9%

NOVNEE

Novartis
CHF 98.850.3%7.2%CHF 200.5bCHF 99.07PE23.4xE9.3%3.1%

NOVN

Novartis
CHF 99.030.9%7.7%CHF 200.5bCHF 99.25PE23.4xE9.3%3.1%

907582

Amgen
US$226.360%n/aUS$145.8bUS$229.35PE19.3xE5.7%3.1%

BMY

Bristol-Myers Squibb
US$54.240%0%US$100.3bUS$58.46PS2.2xE49.0%4.8%

CSJ

CSL
AU$180.920%n/aAU$142.2bAU$190.95PE36.6xE12.9%1.3%

935700

Gilead Sciences
US$68.480%10.5%US$94.1bUS$82.84PE17.2xE7.8%4.0%

1102657

GSK
UK£26.120%-2.8%UK£70.6bUK£34.09PE13.8xE8.9%5.7%

MER

Merck KGaA
€95.60-58.1%n/a€74.6b€103.65PE28.4xE11.9%1.3%

MER

Merck KGaA
€156.78-2.4%n/a€68.5b€186.26PE26.1xE11.9%1.4%

0QF

Moderna
US$184.330%40.6%US$53.4bUS$293.47PE6.4xE-15.5%n/a

LONN

Lonza Group
CHF 531.20-4.3%24.6%CHF 38.4bCHF 624.14PE67xE24.7%0.8%

LONNE

Lonza Group
CHF 532.80-4.2%24.8%CHF 38.4bCHF 626.02PE67xE24.7%0.8%

BAYN

Bayer
€67.990%-66.0%€28.2b€81.22PB0.8xE37.3%0.4%

BIIB

Biogen
US$222.000%0%US$29.3bUS$302.24PE25.1xE17.0%n/a

22UA

BioNTech
US$96.52-2.6%n/aUS$26.8bUS$104.59PS8.9xE-5.3%n/a

GALD

Galderma Group
CHF 81.242.9%n/aCHF 19.3bCHF 80.43PS5.3xE45.1%n/a

TEVA

Teva Pharmaceutical Industries
US$7.850%0%US$19.8bUS$9.53PS1.2xE56.8%0%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.